The use of multifunctional polymers for non-invasive peptide and protein application

被引:8
作者
Bernkop-Schnürch, A [1 ]
机构
[1] Univ Vienna, Ctr Pharm, Inst Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria
关键词
drug delivery systems; multifunctional polymers; non-invasive application; peptide drugs; protein drugs;
D O I
10.1517/13543776.10.9.1357
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
For the efficient delivery of peptide and protein drugs by non-invasive routes various strategies have been pursued to overcome enzymatic and mucosal barriers to gain sufficient bioavailability. Among such delivery systems multifunctional polymers have received considerable attention, which is reflected by numerous publications and patents. They are able to provide a controlled release for therapeutic peptides and proteins being embedded in the polymeric network either based on a simple diffusion process or on the biodegradation of the carrier matrix. Additionally, polymers such as polyacrylates display an inhibitory effect towards various proteases located on the absorption membrane. In combination with enzyme inhibitors, this protective effect towards enzymatic attack may further be improved. Moreover, polyacrylates and chitosan display a permeation enhancing effect, in particular for the paracellular uptake of peptide drugs from mucosal tissues. If these polymers also exhibit mucoadhesive properties, the concentration gradient of the drug on the mucosa can be increased and in the case of oral delivery the presystemic enzymatic degradation of the (poly)peptide drug in the intestine between the delivery system and the absorption membrane can be reduced. Delivery systems utilising multifunctional polymers include formulations such as nano- and microspheres, pellets and matrix-tablets.
引用
收藏
页码:1357 / 1366
页数:10
相关论文
共 64 条
[1]
BERLINER DL, 1996, Patent No. 5849327
[2]
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins [J].
Bernkop-Schnurch, A .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) :1-16
[3]
Polymers with thiol groups:: A new generation of mucoadhesive polymers? [J].
Bernkop-Schnürch, A ;
Schwarz, V ;
Steininger, S .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :876-881
[4]
Basic studies on bioadhesive delivery systems for peptide and protein drugs [J].
Bernkop-Schnürch, A ;
Humenberger, C ;
Valenta, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (02) :217-225
[5]
Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates [J].
Bernkop-Schnurch, A ;
Krajicek, ME .
JOURNAL OF CONTROLLED RELEASE, 1998, 50 (1-3) :215-223
[6]
Bernkop-Schnürch A, 1999, STP PHARMA SCI, V9, P83
[7]
Bernkop-Schnurch A., 1996, Pharm. Pharmacol. Commun, V2, P361, DOI DOI 10.1111/J.2042-7158.1996.TB00632.X
[8]
Synthesis and evaluation of a modified mucoadhesive polymer protecting from alpha-chymotrypsinic degradation [J].
BernkopSchnurch, A ;
Apprich, I .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 146 (02) :247-254
[9]
Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides [J].
BernkopSchnurch, A ;
Schwarz, GH ;
Kratzel, M .
JOURNAL OF CONTROLLED RELEASE, 1997, 47 (02) :113-121
[10]
Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N [J].
BernkopSchnurch, A ;
Paikl, C ;
Valenta, C .
PHARMACEUTICAL RESEARCH, 1997, 14 (07) :917-922